|1.||Harris, William S: 6 articles (11/2013 - 07/2004)|
|2.||Salomon, Robert G: 3 articles (12/2014 - 05/2003)|
|3.||Crabb, John W: 3 articles (12/2014 - 05/2003)|
|4.||Siddiqui, Rafat A: 3 articles (03/2014 - 01/2005)|
|5.||Das, Undurti N: 3 articles (10/2013 - 12/2004)|
|6.||Bazan, Nicolas G: 3 articles (03/2007 - 10/2002)|
|7.||Min, Y: 3 articles (07/2005 - 04/2003)|
|8.||Ghebremeskel, K: 3 articles (07/2005 - 04/2003)|
|9.||Crawford, M A: 3 articles (07/2005 - 04/2003)|
|10.||Belury, Martha A: 2 articles (09/2015 - 04/2015)|
07/01/2007 - "Since fish-derived n-3 fatty acids (FA) have been associated with reduced incidence of myocardial infarction, we investigated the endothelial effects of the most abundant n-3 FA, docosahexaenoate (DHA), on TF expression. "
12/01/1990 - "Dietary eicosapentaenoic and docosahexaenoic acids, which are provided by fish oils, have a protective effect on experimental myocardial infarction. "
09/01/2006 - "For pathological cases, recommendations exist only for coronary disease: 1 g of fish oils : mixture of eicosapentaenoic and docosahexaenoic acids (EPA/DHA) should be given after a myocardial infarction."
03/01/2004 - "Marine omega-3 fatty acids, that is eicosapentaenoic and docosahexaenoic acids, prevent fatal myocardial infarction and sudden cardiac death by their antiarrhythmic effects and presumably also by their effect on infarct size, the latter mediated by plaque stabilization, improvements in endothelial function and other mechanisms. "
09/01/2001 - "Our aim was to study the relationships between a first-ever myocardial infarction, Ery-Hg, activity of gluthathione peroxidase in erythrocytes (Ery-GSH-Px) and plasma concentration of the n-3 PUFA eicosapentaenoic and docosahexaenoic acids (P-PUFA). "
|2.||Hypertension (High Blood Pressure)
03/22/1990 - "Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. "
12/01/1983 - "Docosapentaenoic and docosahexaenoic acids also revealed a marked decrease in rats between 4 and 5 weeks of age indicating that individual polyunsaturated fatty acids (PUFA) change in a different manner which might be relevant to the development of high blood pressure in SHR."
03/22/1990 - "We conducted a population-based, randomized, 10-week dietary-supplementation trial in which the effects of 6 g per day of 85 percent eicosapentaenoic and docosahexaenoic acids were compared with those of 6 g per day of corn oil in 156 men and women with previously untreated stable, mild essential hypertension. "
11/01/2002 - "Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension."
05/01/1997 - "Seventy-eight persons with untreated hypertension were included in a 16-week, double-blind, randomized, controlled intervention study with 4 g/d of eicosapentaenoic and docosahexaenoic acids or corn oil placebo. "
|3.||Wounds and Injuries (Trauma)
06/01/1998 - "Studies were conducted on the prenatal rat given a single intraamniotic injection of ethyl docosahexaenoate (Et-DHA; 9.6-12 mmol per fetus) or subjected to an n-3 fatty acid-deficient diet to assess the role of docosahexaenoate on oxidative stress during episodes of ischemia. "
04/01/2006 - "Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion."
10/31/2003 - "These results challenge the view that docosahexaenoate only participates in brain damage and demonstrate that this fatty acid is also the endogenous precursor to a neuroprotective signaling response to ischemia-reperfusion."
11/19/2005 - "Therefore, in the present study, we investigated the effects of chronic ethyl docosahexaenoate (E-DHA) administration on mortality and cerebral edema induced by transient forebrain ischemia in gerbils. "
04/01/2006 - "The purpose of the present study was to investigate the effects of chronic ethyl docosahexaenoate (E-DHA) administration on the generation of eicosanoids of AA metabolism during the period of reperfusion after ischemia in gerbils. "
11/01/1987 - "The present studies were conducted to determine if eicosapentaenoic and docosahexaenoic acids can modify the growth of DU-145 human prostatic tumor cells in nude mice. "
02/20/2007 - "Arachidonic and docosahexaenoic acids reduce the growth of A549 human lung-tumor cells increasing lipid peroxidation and PPARs."
12/15/2014 - "Oxidation of docosahexaenoate phospholipids produces 4-hydroxy-7-oxo-hept-5-eonyl phospholipids (HOHA-PLs) that react with protein lysyl ε-amino residues to generate 2-ω-carboxyethylpyrrole (CEP) derivatives, endogenous factors that induce angiogenesis in the retina and tumors. "
05/01/2010 - "Intake of individual eicosapentaenoic acids and docosahexaenoic acids was inversely related to distal large bowel cancer risk, whereas the ratio of omega-6 to long-chain omega-3 PUFAs was associated with increased risk of distal large bowel cancer in whites, but not among African Americans (P(interaction) < 0.05). "
09/01/1992 - "eicosapentaenoic acids (C20:5n-3) and docosahexaenoic acids (C22:5n-3), have an inhibiting effect on tumor growth. "
|1.||Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
|2.||Omega-3 Fatty Acids (Omega 3 Fatty Acids)
|3.||Fatty Acids (Saturated Fatty Acids)
|4.||alpha-Linolenic Acid (Linolenic Acid)
|7.||Corn Oil (Oil, Corn)
|2.||Intensive Care (Surgical Intensive Care)
|3.||Transplantation (Transplant Recipients)